Gossamer Bio (GOSS) Debt to Equity (2022 - 2024)
Historic Debt to Equity for Gossamer Bio (GOSS) over the last 3 years, with Q1 2024 value amounting to $0.36.
- Gossamer Bio's Debt to Equity rose 14901.24% to $0.36 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.36, marking a year-over-year increase of 14901.24%. This contributed to the annual value of $0.2 for FY2023, which is 8986.91% down from last year.
- Gossamer Bio's Debt to Equity amounted to $0.36 in Q1 2024, which was up 14901.24% from $0.2 recorded in Q4 2023.
- Gossamer Bio's 5-year Debt to Equity high stood at $1.95 for Q4 2022, and its period low was -$1.07 during Q2 2022.
- Moreover, its 3-year median value for Debt to Equity was $0.2 (2023), whereas its average is $0.2.
- Per our database at Business Quant, Gossamer Bio's Debt to Equity crashed by 17570.49% in 2023 and then soared by 14901.24% in 2024.
- Gossamer Bio's Debt to Equity (Quarter) stood at $1.95 in 2022, then plummeted by 89.87% to $0.2 in 2023, then skyrocketed by 81.25% to $0.36 in 2024.
- Its last three reported values are $0.36 in Q1 2024, $0.2 for Q4 2023, and $0.15 during Q3 2023.